✦ LIBER ✦

Efficacy of low-dose imatinib in chronic-phase chronic myelogenous leukemia patients

✍ Scribed by Shinichi Kobayashi; Fumihiko Kimura; Ayako Kobayashi; Ken Sato; Kazuo Motoyoshi

Book ID: 111706984
Publisher: Springer
Year: 2008
Tongue: English
Weight: 190 KB
Volume: 88
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0589-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of low-dose imatinib in chronic

Efficacy of low-dose imatinib in chronic-phase chronic myelogenous leukemia patients

✍ S. Kobayashi; F. Kimura; A. Kobayashi; K. Sato; K. Motoyoshi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 41 KB

Efficacy of imatinib dose escalation in

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 3 views

Erratum: Efficacy of imatinib dose escal

Erratum: Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Late response to low-dose imatinib in pa

Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia

✍ Akiyoshi Takami, Shigeki Ohtake, Eriko Morishita… 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 230 KB

Phase 1 study of tipifarnib in combinati

Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure

✍ Jorge Cortes; Alfonso Quintás-Cardama; Guillermo Garcia-Manero; Susan O'Brien; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## BACKGROUND. The tolerability and efficacy of the combination of tipifarnib, an orally bioavailable nonpeptidomimetic farnesyl transferase inhibitor, and imatinib was investigated in patients with chronic myelogenous leukemia in chronic phase who had failed imatinib. ## METHODS. Tw

Persistent neutropenia in chronic myelog

Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

✍ Yu-Yan Hwang; Eric Tse; Jason C.C. So; Thomas S.K. Wan; Yok-Lam Kwong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

A physician or a group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary.